av/mithra--big.svg

COM:MITHRA

Mithra Pharmaceuticals SA

  • Stock

EUR

Last Close

0.22

23/07 20:00

Market Cap

14.93M

Beta: -

Volume Today

82.37K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
2.41M
-
2.09M
13.45%
2.28M
9.20%
3.48M
52.79%
4.16M
19.29%
7.54M
81.52%
13.61M
80.45%
25.83M
89.77%
39.62M
53.38%
47.08M
18.84%
49.30M
4.71%
average payables
2.00M
-
3.99M
99.40%
5.00M
25.48%
6.96M
39.17%
12.73M
82.79%
14.61M
14.77%
16.26M
11.32%
21.39M
31.53%
20.12M
5.92%
24.32M
20.85%
45.39M
86.69%
average receivables
3.03M
-
4.20M
38.64%
6.77M
61.26%
8.00M
18.09%
19.76M
147.01%
27.26M
37.99%
23.87M
12.43%
44.54M
86.57%
42.71M
4.11%
44.11M
3.28%
49.34M
11.87%
book value per share
0.08
-
0.28
245.57%
4.09
1,353.76%
2.99
26.99%
2.66
10.97%
4.13
55.13%
4.33
4.82%
3.85
11.03%
0.78
79.75%
0.69
11.88%
capex per share
-0.03
-
-0.11
301.65%
-0.37
236.50%
-0.52
40.51%
-0.37
27.80%
-0.28
26.05%
-0.41
48.22%
-0.40
3.28%
-0.49
23.17%
-0.52
7.23%
capex to depreciation
-1.41
-
-2.91
106.37%
-17.26
494.11%
-15.34
11.14%
-5.66
63.11%
-3.54
37.39%
-2.68
24.48%
-1.66
37.89%
-2.03
22.26%
-2.15
5.77%
capex to operating cash flow
-1.61
-
3.19
297.85%
0.63
80.11%
0.65
2.86%
0.35
46.48%
-2.85
916.26%
0.33
111.58%
0.20
38.55%
0.28
40.40%
0.45
58.58%
capex to revenue
-0.05
-
-0.11
139.61%
-0.56
397.32%
-0.72
27.80%
-0.26
63.21%
-0.17
33.84%
-0.16
8.24%
-1.80
1,022.48%
-0.93
48.01%
-0.38
59.02%
cash per share
0.05
-
0.11
110.69%
3.11
2,787.66%
1.47
52.73%
1.11
24.60%
3.25
193.58%
1.32
59.48%
3.38
156.68%
0.54
83.97%
0.58
6.28%
days of inventory on hand
97.28
-
64.43
33.77%
100.14
55.43%
168.57
68.34%
166.19
1.42%
2.54K
1,430.16%
2.39K
6.06%
3.74K
56.38%
1.02K
72.75%
935.83
8.07%
515.91
44.87%
days payables outstanding
104.05
-
197.08
89.41%
165.15
16.20%
376.44
127.93%
647.77
72.08%
3.04K
368.82%
2.85K
6.01%
2.46K
13.72%
392.65
84.06%
589.94
50.25%
631.11
6.98%
days sales outstanding
74.23
-
92.12
24.10%
156.13
69.48%
117.86
24.51%
254.55
115.98%
140.42
44.84%
96.36
31.38%
2.57K
2,567.88%
351.35
86.33%
361.74
2.96%
328.07
9.31%
debt to assets
0.39
-
0.82
107.34%
0.10
87.55%
0.10
0.69%
0.27
163.19%
0.22
15.81%
0.20
12.65%
0.36
83.72%
0.52
45.84%
0.52
1.30%
0.61
17.77%
debt to equity
1.88
-
9.01
378.69%
0.16
98.18%
0.19
14.26%
0.75
299.26%
0.53
29.55%
0.48
9.77%
1.19
149.67%
6.52
449.49%
6.78
3.96%
-1.69
124.88%
dividend yield
0.00
-
0.01
524.57%
earnings yield
-0.00
-
-0.05
1,059.20%
-0.03
35.60%
-0.12
298.96%
-0.10
16.86%
-0.02
83.69%
-0.03
62.43%
-0.11
315.31%
-0.13
18.10%
-0.36
164.98%
enterprise value
368.11M
-
282.18M
23.34%
327.34M
16.01%
296.68M
9.37%
366.49M
23.53%
691.85M
88.78%
1.02B
47.33%
856.03M
16.02%
1.06B
23.31%
367.19M
65.21%
196.88M
46.38%
enterprise value over ebitda
-10.52K
-
-29.00
99.72%
-19.71
32.02%
-8.27
58.05%
-15.61
88.74%
-22.19
42.15%
-39.18
76.57%
-9.23
76.44%
-11.04
19.61%
24.52
322.03%
-3.45
114.06%
ev to operating cash flow
713.40
-
-419.29
158.77%
-18.12
95.68%
-12.02
33.65%
-10.49
12.71%
195.33
1,961.17%
-21.77
111.14%
-10.70
50.86%
-14.19
32.66%
-6.46
54.46%
-90.15
1,294.96%
ev to sales
20.82
-
14.82
28.82%
16.02
8.08%
13.20
17.57%
7.92
39.99%
11.95
50.86%
10.56
11.66%
94.80
797.68%
46.57
50.88%
5.48
88.23%
4.90
10.54%
free cash flow per share
-0.01
-
-0.14
1,289.00%
-0.95
559.99%
-1.31
38.12%
-1.44
10.13%
-0.18
87.57%
-1.65
819.97%
-2.35
42.35%
-2.20
6.29%
-1.68
23.60%
free cash flow yield
-0.00
-
-0.01
1,289.00%
-0.09
681.27%
-0.14
54.24%
-0.14
3.72%
-0.01
93.57%
-0.06
600.66%
-0.12
89.75%
-0.11
7.61%
-0.49
348.29%
graham net net
-0.13
-
-2.49
1,825.64%
0.85
134.23%
-0.85
199.43%
-2.92
244.29%
-1.74
40.37%
-4.17
139.33%
-3.91
6.23%
-7.51
92.22%
-6.23
17.10%
graham number
0.30
-
1.92
532.92%
5.39
181.22%
8.70
61.51%
8.01
7.99%
5.60
30.05%
8.38
49.52%
13.95
66.49%
6.87
50.75%
4.33
36.92%
income quality
-0.93
-
0.23
124.81%
1.27
450.85%
0.69
45.83%
1.66
141.51%
0.10
93.97%
-1.34
1,440.28%
0.96
171.43%
0.85
11.48%
2.16
155.75%
0.01
99.42%
intangibles to total assets
0.14
-
0.75
414.16%
0.42
43.69%
0.49
16.44%
0.35
28.38%
0.24
29.98%
0.23
4.82%
0.18
22.58%
0.26
44.66%
0.32
21.29%
0.02
94.23%
interest coverage
-3.90
-
-7.73
98.36%
-33.18
329.43%
-205.58
519.60%
-12.33
94.00%
4.10
133.26%
7.84
91.28%
-23.89
404.55%
-7.47
68.73%
0.18
102.39%
-3.03
1,794.74%
interest debt per share
0.16
-
2.60
1,543.99%
0.68
73.65%
0.57
17.44%
2.04
261.19%
2.27
11.13%
2.14
5.49%
4.65
117.00%
5.35
15.04%
5.00
6.55%
inventory turnover
3.75
-
5.67
50.99%
3.64
35.66%
2.17
40.60%
2.20
1.44%
0.14
93.46%
0.15
6.45%
0.10
36.05%
0.36
266.99%
0.39
8.77%
0.71
81.40%
invested capital
1.88
-
9.01
378.69%
0.16
98.18%
0.19
14.26%
0.75
299.26%
0.53
29.55%
0.48
9.77%
1.19
149.67%
6.52
449.49%
6.78
3.96%
-1.69
124.88%
market cap
364.99M
-
234.50M
35.75%
314.25M
34.01%
281.41M
10.45%
337.71M
20.00%
731.29M
116.55%
991.36M
35.56%
807.47M
18.55%
867.73M
7.46%
167.05M
80.75%
net current asset value
-1.31M
-
-46.81M
3,465.35%
30.90M
166.00%
-21.80M
170.58%
-83.62M
283.48%
-51.12M
38.86%
-142.82M
179.37%
-125.77M
11.94%
-288.69M
129.53%
-262.86M
8.95%
-296.39M
12.76%
net debt to ebitda
-89.26
-
-4.90
94.51%
-0.79
83.91%
-0.43
46.00%
-1.23
187.96%
1.27
203.20%
-1.07
184.82%
-0.52
51.20%
-1.97
275.25%
13.36
780.05%
-3.45
125.80%
net income per share
-0.05
-
-0.58
1,059.20%
-0.32
45.60%
-1.13
257.27%
-1.07
4.91%
-0.34
68.45%
-0.72
113.27%
-2.25
211.56%
-2.69
19.78%
-1.22
54.84%
operating cash flow per share
0.02
-
-0.03
303.00%
-0.58
1,591.98%
-0.79
36.60%
-1.07
34.89%
0.10
109.06%
-1.24
1,380.45%
-1.95
57.40%
-1.71
12.27%
-1.16
32.38%
payables turnover
3.51
-
1.85
47.20%
2.21
19.33%
0.97
56.13%
0.56
41.89%
0.12
78.67%
0.13
6.39%
0.15
15.90%
0.93
527.21%
0.62
33.44%
0.58
6.52%
receivables turnover
4.92
-
3.96
19.42%
2.34
41.00%
3.10
32.47%
1.43
53.70%
2.60
81.28%
3.79
45.73%
0.14
96.25%
1.04
631.66%
1.01
2.87%
1.11
10.26%
research and ddevelopement to revenue
0.08
-
0.47
504.61%
0.46
1.46%
1.53
228.68%
1.04
31.76%
0.62
40.77%
0.59
4.17%
8.69
1,369.39%
3.76
56.72%
0.96
74.58%
1.57
64.58%
return on tangible assets
-0.15
-
-0.73
387.33%
-0.08
88.75%
-0.40
382.66%
-0.22
44.61%
-0.05
79.08%
-0.09
93.93%
-0.22
141.14%
-0.37
74.15%
-0.20
47.39%
-0.62
212.70%
revenue per share
0.58
-
0.97
67.63%
0.66
32.34%
0.72
9.95%
1.42
96.21%
1.58
11.77%
2.56
61.53%
0.22
91.38%
0.52
136.92%
1.37
161.64%
roe
-0.61
-
-2.06
235.44%
-0.08
96.26%
-0.38
389.31%
-0.40
6.81%
-0.08
79.67%
-0.17
103.47%
-0.58
250.19%
-3.45
491.59%
-1.77
48.76%
1.68
194.94%
roic
-0.15
-
-0.16
6.08%
-0.06
60.50%
-0.28
335.04%
-0.09
69.60%
0.04
143.56%
0.07
100.61%
-0.18
334.49%
-0.27
56.09%
0.05
118.88%
-0.72
1,503.48%
sales general and administrative to revenue
0.25
-
0.35
43.01%
0.51
43.20%
0.37
27.57%
0.19
48.64%
0.16
17.49%
0.15
1.34%
1.76
1,052.73%
0.55
68.71%
0.22
60.33%
shareholders equity per share
0.08
-
0.28
245.57%
4.09
1,353.76%
2.99
26.99%
2.66
10.97%
4.13
55.13%
4.33
4.82%
3.85
11.03%
0.78
79.75%
0.69
11.88%
stock based compensation to revenue
0.03
-
0.03
6.62%
0.02
31.94%
0.02
7.47%
0.05
148.69%
0.80
1,485.86%
0.05
94.16%
0.03
37.00%
tangible asset value
763K
-
-39.94M
5,334.47%
41.14M
203.02%
8.65M
78.97%
1.26M
85.39%
63.75M
4,943.75%
70.58M
10.70%
63.50M
10.03%
-76.35M
220.23%
-106.45M
39.43%
-108.49M
1.92%
tangible book value per share
0.02
-
-2.04
8,247.26%
1.32
164.94%
0.28
78.97%
0.04
86.08%
1.74
4,405.16%
1.87
7.22%
1.55
17.13%
-1.76
213.47%
-2.17
23.43%
working capital
-74K
-
-20.23M
27,243.24%
74.55M
468.43%
30.17M
59.53%
22.00M
27.10%
117.59M
434.60%
43.72M
62.82%
167.73M
283.62%
3.60M
97.86%
15.43M
329.14%
-10.57M
168.51%

All numbers in EUR (except ratios and percentages)